Cellectis S.A. (CLLS)
NASDAQ: CLLS · IEX Real-Time Price · USD
1.890
-0.045 (-2.33%)
At close: Jul 2, 2024, 3:57 PM
2.100
+0.210 (11.11%)
After-hours: Jul 2, 2024, 7:54 PM EDT
Cellectis Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cellectis stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 323.28% from the current stock price of 1.89.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cellectis stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +429.10% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +217.46% | May 31, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +217.46% | Nov 1, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +482.01% | Aug 8, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +217.46% | Aug 7, 2023 |
Financial Forecast
Revenue This Year
21.11M
from 9.19M
Increased by 129.63%
Revenue Next Year
70.56M
from 21.11M
Increased by 234.25%
EPS This Year
-0.81
from -1.77
EPS Next Year
-1.04
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.5M | 115.3M | 141.0M | 87.5M | 123.9M |
| Avg | 21.1M | 70.6M | 132.4M | 85.9M | 121.6M |
| Low | 15.5M | 29.4M | 120.3M | 81.7M | 115.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 231.2% | 446.2% | 99.9% | -33.9% | 44.3% |
| Avg | 129.6% | 234.2% | 87.7% | -35.1% | 41.6% |
| Low | 68.4% | 39.3% | 70.5% | -38.3% | 34.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.57 | -0.54 | -0.01 |
| Avg | -0.81 | -1.04 | -0.01 |
| Low | -1.01 | -1.37 | -0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.